Screener
Gilead Sciences GILD Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $3.18B-38.2% | $7.63B-3.8% | $7.56B-24.3% | $7.33B+45.5% | $5.14B+85.6% | ||
| $0-100% | $15M— | $68M— | $19M— | $69M— | ||
| $5.9B+5.0% | $5.54B+5.5% | $5.9B+10.8% | $5.99B+9.7% | $5.62B+2.5% | ||
| $2.35B+12.4% | $2.42B+20.1% | $2.59B+38.1% | $2.6B+66.2% | $2.09B+53.2% | ||
| $13.95B-5.3% | $18.64B+10.3% | $18.34B-4.3% | $17.87B+20.9% | $14.72B+19.5% | ||
| $5.83B+6.9% | $5.64B+4.0% | $5.61B+3.5% | $5.5B+2.0% | $5.46B+2.1% | ||
| $8.31B0.0% | $8.31B0.0% | $8.31B0.0% | $8.31B0.0% | $8.31B0.0% | ||
| $14.03B-11.6% | —— | $14.68B-26.4% | $15.27B-13.5% | $15.87B-12.8% | ||
| $49.36B-11.4% | $56.28B-0.3% | $59.02B0.0% | $58.53B+7.4% | $55.72B+4.0% | ||
| $674M+15.8% | $645M-12.5% | $715M-14.2% | $808M-10.5% | $582M+8.4% | ||
| $2.41B-14.0% | $1.31B-53.2% | $2.81B+54.7% | $2.81B+54.9% | $2.81B+55.1% | ||
| $11.02B-1.5% | $9.48B-23.2% | $11.81B-1.6% | $12.3B+4.9% | $11.19B+3.8% | ||
| $23.83B+7.6% | $20.86B-5.8% | $22.13B-11.1% | $22.14B+3.3% | $22.14B+2.8% | ||
| $535M— | —— | $757M— | —— | —— | ||
| 5.6B0.0% | —— | 5.6B+559,900% | 5.6B0.0% | 5.6B0.0% | ||
| $2.2B-80.6% | $14.13B+29.3% | $13.73B+19.4% | $12.83B+15.8% | $11.33B+1.4% | ||
| $11.83B-39.9% | $23.52B+22.7% | $22.7B+17.4% | $21.54B+16.6% | $19.67B+7.6% | ||
| $49.36B-11.4% | $56.28B-0.3% | $59.02B0.0% | $58.53B+7.4% | $55.72B+4.0% |
FAQ
- What are Gilead Sciences's total assets?
- Gilead Sciences (GILD) holds $49.4B in total assets, down 11.4% year over year.
- How much debt does Gilead Sciences have?
- Gilead Sciences carries $26.2B in total debt against $11.8B of shareholders' equity, a debt-to-equity ratio of 2.22.
- How much cash does Gilead Sciences have?
- Gilead Sciences holds $3.2B in cash and equivalents.
- Can Gilead Sciences cover its short-term obligations?
- Its current ratio is 1.27 — current assets exceed current liabilities.
- Where does Gilead Sciences's balance sheet data come from?
- Every line is extracted from Gilead Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
